XML 159 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity (Deficit) (Tables)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Subsidiary or Equity Method Investee [Line Items]    
Schedule of Company Nonvested Series A and B of Common Stock

A summary of the Company’s nonvested shares (due to service based restrictions) as of March 31, 2024 and December 31, 2023, is presented below:

 

Non-Vested Shares  Number of Shares   Weighted Average Grant Date Fair Value 
Balance - December 31, 2022   42,191   $1.40 
Granted   330,554    5.77 
Vested   (104,698)   6.72 
Cancelled/Forfeited   (153,711)   5.53 
Balance - December 31, 2023   114,336    5.43 
Granted   -    - 
Vested   -    - 
Cancelled/Forfeited   -    - 
Balance - March 31, 2024   114,336   $5.43 

A summary of the Company’s nonvested shares (due to service based restrictions) as of December 31, 2023 and 2022, is presented below: 

 

Non-Vested Shares  Number of
Shares		   Weighted Average
Gant Date
Fair Value		 
Balance - December 31, 2021   15,878   $8.18 
Granted   48,340    12.60 
Vested   (20,277)   53.80 
Cancelled/Forfeited   (1,750)   40.00 
Balance - December 31, 2022   42,191    1.40 
Granted   330,554    5.77 
Vested   (104,698)   6.72 
Cancelled/Forfeited   (153,711)   5.53 
Balance - December 31, 2023   114,336   $5.43 
Schedule of Stock Option Activity

Stock option transactions for the year ended December 31, 2023 is summarized as follows:

 

Stock Options  Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding - December 31, 2022   37,392   $19.05    3.68   $        -   $- 
Vested and Exercisable - December 31, 2022   34,526   $19.44    3.47   $-   $- 
Unvested and non-exercisable - December 31, 2022   2,866   $14.36    4.16   $-   $- 
Granted   101,930   $17.41             $0.73 
Exercised   -   $-                
Cancelled/Forfeited   (139,322)  $17.85                
Outstanding - December 31, 2023   -   $-    -   $-   $- 
Vested and Exercisable - December 31, 2023   -   $-    -   $-   $- 
Unvested and non-exercisable - December 31, 2023   -   $-    -   $-   $- 

Stock option transactions for the years ended December 31, 2023 and 2022 are summarized as follows:

 

Stock Options  Number of
Options		   Weighted
Average
Exercise Price		   Weighted
Average
Remaining
Contractual
Term (Years)		   Aggregate
Intrinsic
Value		   Weighted
Average
Grant
Date
Fair Value		 
Outstanding - December 31, 2021   8,769   $35.60    3.25   $     -   $- 
Vested and Exercisable - December 31, 2021   8,769   $35.60    3.25   $-   $- 
Unvested and non-exercisable - December 31, 2021   -   $-    -   $-   $- 
Granted   28,623   $13.97             $12.49 
Exercised   -    -                
Cancelled/Forfeited   -    -                
Outstanding - December 31, 2022   37,392   $19.05    3.68   $-   $- 
Vested and Exercisable - December 31, 2022   34,526   $19.44    3.47   $-   $- 
Unvested and non-exercisable - December 31, 2022   2,866   $14.36    4.16   $-   $- 
Granted   101,930   $17.41             $0.73 
Exercised   -   $-                
Cancelled/Forfeited   (139,322)  $17.85                
Outstanding - December 31, 2023   -   $-    -   $-   $- 
Vested and Exercisable - December 31, 2023   -   $-    -   $-   $- 
Unvested and non-exercisable - December 31, 2023   -   $-    -   $-   $- 
Schedule of Fair Value Assumptions

The fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions:

 

Expected term (years)   5.00  
Expected volatility   59% - 62 %
Expected dividends   0 %
Risk free interest rate   4.00 %

The fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions:

 

Expected term (years)   5.00 
Expected volatility   59% - 62% 
Expected dividends   0%
Risk free interest rate   4.00%
 
Expected term (years)   5.00 
Expected volatility   62%
Expected dividends   0%
Risk free interest rate   1.64%
 
Schedule of Stock Warrant Activity

Warrant activity for the three months ended March 31, 2024 and the year ended December 31, 2023 are summarized as follows:

 

Warrants  Number of Warrants   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
Outstanding - December 31, 2022   81,452   $10.36    2.22   $82,756 
Vested and Exercisable - December 31, 2022   81,452   $10.36    2.22   $82,756 
Unvested - December 31, 2022   -   $-    -   $- 
Granted   -                
Exercised   -                
Cancelled/Forfeited   -                
Outstanding - December 31, 2023   81,452   $10.36    1.22   $36,030 
Vested and Exercisable - December 31, 2023   81,452   $10.36    1.22   $36,030 
Unvested and non-exercisable - December 31, 2023   -   $-    -   $- 
Granted   -                
Exercised   -                
Cancelled/Forfeited   -                
Outstanding - March 31, 2024   81,452   $10.36    0.98   $42,727 
Vested and Exercisable - March 31, 2024   81,452   $10.36    0.98   $42,727 
Unvested and non-exercisable - March 31, 2024   -   $-    -   $- 

Warrant activity for the years ended December 31, 2023 and 2022 are summarized as follows:

 

Warrants  Number of
Warrants		   Weighted
Average
Exercise Price		   Weighted
Average
Remaining
Contractual
Term (Years)		   Aggregate
Intrinsic
Value		 
Outstanding - December 31, 2021   81,452   $10.36    3.22   $- 
Vested and Exercisable - December 31, 2021   81,452   $10.36    3.22   $- 
Unvested - December 31, 2021   -   $-    -   $- 
Granted   -                
Exercised   -                
Cancelled/Forfeited   -                
Outstanding - December 31, 2022   81,452   $10.36    2.22   $82,756 
Vested and Exercisable - December 31, 2022   81,452   $10.36    2.22   $82,756 
Unvested - December 31, 2022   -   $-    -   $- 
Granted   -                
Exercised   -                
Cancelled/Forfeited   -                
Outstanding - December 31, 2023   81,452   $10.36    1.22   $36,030 
Vested and Exercisable - December 31, 2023   81,452   $10.36    1.22   $36,030 
Unvested and non-exercisable - December 31, 2023   -   $-    -   $- 
Next NRG Holding Corp [Member]    
Subsidiary or Equity Method Investee [Line Items]    
Schedule of Company Nonvested Series A and B of Common Stock

The following is a summary of the Company’s non-vested Series A and B shares of common stock at March 31, 2024 and December 31, 2023, respectively:

      

Weighted

Average

 
Non-Vested Shares 

Number

of Shares

  

Grant Date

Fair Value

 
Balance - December 31, 2023   -   $- 
Granted   4,500,000    2.03 
Vested   -    - 
Cancelled/Forfeited   -    - 
Balance - March 31, 2024   4,500,000   $2.03 
           
Unrecognized Compensation  $8,944,688      
           
Weighted average remaining period (years)   3.92      
  
Related Party [Member]    
Subsidiary or Equity Method Investee [Line Items]    
Schedule of Classes of stock

The following represents the Company’s three (3) classes of stock:

  

March 31, 2024
  

Shares

Authorized

   Issued   Outstanding   Designated   Par Value   Votes Per Share 
                         
Preferred Stock                              
Series X   50,000,000    1    1    1   $0.00001    A 
                               
Common Stock                              
Series A   500,000,000    17,700,000    15,000,000        $0.00001    1 
Series B   500,000,000    11,800,000    10,000,000        $0.00001    10 
    1,000,000,000    29,500,000    25,000,000    -           

 

A - Series X will have a number of votes at any time equal to all of the number of votes held by all other voting equity securities, plus one share. Currently, the Series X preferred stockholder controls the Company through their super voting rights.

 

December 31, 2023
  

Shares

Authorized

   Issued   Outstanding   Designated   Par Value   Votes Per Share 
                         
Common Stock                        
Series A   500,000,000    17,700,000    15,000,000        $0.00001    1 
Series B   500,000,000    11,800,000    10,000,000        $0.00001    10 
    1,000,000,000    29,500,000    25,000,000    -